Hyundai Bioscience

048410.KQ

9.44 USD

-0.05

-0.53%

Overview

Last close

9.44 usd

Market cap

906.95M usd

52 week high

9.49 usd

52 week low

3.13 usd

Target price

N/A usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

664.8207

Price/Book Value

11.9652

Enterprise Value

891.31M usd

EV/Revenue

658.1727

EV/EBITDA

-64.6317

Key financials

Revenue TTM

1.35M usd

Gross Profit TTM

56194.25 usd

EBITDA TTM

-10.62M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

83.26M usd

Net debt

N/A usd

About

Hyundai Bioscience Co., Ltd. operates as a biotechnology company. The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19. The company was founded in 2000 and is based in Seoul, South Korea.